Skip to main content

Generics

  • Teva reaches settlements in Nuvigil patent case

    JERUSALEM — Teva has reached settlements with Sandoz, Actavis, Lupin and Apotex with respect to a patent for Teva’s wakefulness product, Nuvigil (armodafinil) tablets. These settlements dismiss a pending appeal with the United States Court of Appeals for the Federal Circuit of a trial court decision that found the “570 patent” to be valid and infringed.

  • Teva to move forward with generic equivalent of BMS' Baraclude

    JERUSALEM — Teva Pharmaceutical Industries on Thursday announced that the U.S. Court of Appeals for the Federal Circuit upheld a ruling by the U.S. District Court for the District of Delaware finding Bristol-Myers Squibb's entecavir compound claim of U.S. Patent No. 5,206,244 invalid. 

  • Fight the Fakes anti-counterfeit medicine coalition adds 11 partners

    GENEVA — Following the campaign's six-month anniversary, Fight the Fakes last week announced 11 new partners, bringing the total number of member organizations to 25. New partners, representing wholesalers, pharmacists, mobile app services, coalitions for consumer protection and generic pharmaceutical manufactures, join the campaign to speak up and spread the word about the impact of fake medicines.

  • Auxilium, Prasco partner for generic Testim

    CHESTERBROOK, Pa. — Auxilium Pharmaceuticals, a specialty biopharmaceutical company, on Wednesday announced that it has partnered with Prasco to debut the authorized generic form of Testim gel, which is used to treat adult males with low or no testosterone.

  • Study: Metformin with insulin associated with a higher risk of all-cause death

    CHICAGO — A study published Wednesday on JAMA's website found that diabetes patients taking metformin had a higher risk of all-cause death when insulin was added to their treatment as compared to when sulfonylureas were added to treatment.

  • Industry-supported bill on prescription drug diversion passes House committee

    WASHINGTON — The House Energy and Commerce Committee on Tuesday advanced bipartisan legislation sponsored by full committee vice chair Marsha Blackburn to address the nation’s growing prescription drug abuse epidemic. 

  • QS/1 partnering with VUCA Health to offer on-demand prescription-specific videos

    SPARTANBURG, S.C. — QS/1, a complete healthcare automation solutions provider, on Tuesday announced it is partnering with VUCA Health to offer on-demand prescription-specific videos, as well as other services to engage patients and strengthen customer relationships.

    QS/1 pharmacies will be able to print QR codes on prescription labels that link to thousands of videos in the MedsOnCue library. The videos help patients review how to take their medications safely with easy to understand information on potential side effects and how to limit any avoidable reactions.

  • CDC: 9.3% of U.S. population has diabetes

    ATLANTA - More than 29 million people in the United States have diabetes, up from the previous estimate of 26 million in 2010, according to a report released Tuesday by the Centers for Disease Control and Prevention. One-in-four people with diabetes doesn’t know he or she has it.

X
This ad will auto-close in 10 seconds